The μ opioid receptor crystal structure with BU72 is a covalent adduct

12 December 2022, Version 4
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Background The first crystal structure of the active μ opioid receptor (μOR) exhibited several unexplained features. The ligand BU72 exhibited many extreme deviations from ideal geometry, along with unexplained electron density around the benzylic carbon. I previously showed that inverting the benzylic configuration resolved these problems, establishing revised stereochemistry of BU72 and its analog BU74. However, another problem remains unresolved: additional unexplained electron density contacts both BU72 and a histidine residue in the N-terminus. Results Here I show that these short contacts and uninterrupted density are inconsistent with non-covalent interactions. Therefore, BU72 and μOR form a covalent adduct through an unmodeled atom, and the published model as two separate entities is incorrect. A subsequently proposed magnesium complex is also inconsistent with multiple lines of evidence. However, oxygen fits the unexplained density well. While the structure I propose is tentative, similar oxygen-bridged adducts have been reported previously in the presence of reactive oxygen species. Moreover, known sources of reactive oxygen species were present: HEPES buffer, nickel ions, and a sequence motif that forms redox-active nickel complexes. This motif contacts the unexplained density. The adduct exhibits severe strain, and the tethered N-terminus forms contacts with adjacent residues. These forces, along with the nanobody used as a G protein substitute, would be expected to influence the receptor conformation. Consistent with this, the intracellular end of the structure differs markedly from subsequent structures of active μOR bound to Gi protein. Conclusions Later Gi-bound structures are likely to be more accurate templates for docking and molecular dynamics simulations of active μOR. The possibility of reactions like this should be considered in the choice of protein truncation sites and purification conditions, and in the interpretation of excess or unexplained density.

Keywords

BU72
μ opioid receptor
crystal structure
covalent adduct
revised structure

Supplementary materials

Title
Description
Actions
Title
BU72 adduct v4 Supplementary Information
Description
Additional file 1: BU72-Mg-muOR model.cif Coordinates of the BU72-Mg2+-µOR complex Additional file 2: BU72-Mg-muOR phases.mtz Structure factors of the BU72-Mg2+-µOR complex Additional file 3: BU72-muOR adduct model.cif Coordinates of the BU72-µOR adduct Additional file 4: BU72-muOR adduct phases.mtz Structure factors of the BU72-µOR adduct Additional file 5: BU72-histidine adduct ideal structure.pdb Ideal coordinates of BU72-histidine adduct 6 (GRADE server) Additional file 6: BU72-histidine adduct restraints.cif Geometric restraints of BU72-histidine adduct 6 (GRADE server) Additional file 7: GRADE ligand outliers.xlsx Geometric outliers of BU72 and the BU72-µOR adduct (GRADE server) Additional file 8: chemical structures.cml Chemical structures (structural formulae) of the small molecules
Actions

Supplementary weblinks

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.